Base de gel Cica apaisant

1. INCI et CAS

INCI: Madecassoside · CAS: 34540-22-2

2. Rôle dans la formule

Madecassoside is listed as a Centella-associated glycoside in the formulation reference. The recorded formula also lists Centella Asiatica Extract and Asiaticoside. Review this ingredient within the recorded combination; finished-formula comfort claims require supporting evidence.

3. Niveaux d'emploi typiques (repère de formulation)

• A component allocation of 0.3% w/w is listed as guidance.

Dissolve into water or an approved solvent. Avoid a long high-heat hold after addition.

4. Sources réglementaires et conformité mondiale

• This formulation note is a guide for development; it does not constitute approval of the supplied grade or final cosmetic; The finished cosmetic is outside the approval represented by this note.

5. Sécurité et évaluation des risques

Treat the listed amount as cosmetic-development guidance; the note establishes neither drug approval nor OTC-monograph status so patch response and stability should be checked on the finished product.

6. Stabilité et conditionnement

Hold the bulk material in a sealed, cool place shielded from light; take oxidation sensitivity into account when selecting the final pack; confirm final stability and pack compatibility on a representative batch.

7. Formulations d'allégations (à faire / à éviter)

• The cosmetic concept for Madecassoside in this entry centers on Centella marker.

• The ingredient record does not establish therapeutic effects, curative outcomes, or unsupported certification statements.
• This Madecassoside listing should not be used to substantiate a whitening effect, acne treatment, perspiration control, sun protection, or hair growth.

1. INCI et CAS

INCI: Centella Asiatica Extract · CAS: 84696-21-9

2. Rôle dans la formule

Centella Asiatica Extract is listed as a botanical ingredient in this development reference. The recorded formula also lists Madecassoside and Asiaticoside. Review the supplied grade and its contribution within the complete formula.

3. Niveaux d'emploi typiques (repère de formulation)

• This guide records a component allocation of 1.5% w/w.

Add in cool-down when the carrier is heat-sensitive. Guide pH about 5–6.

4. Sources réglementaires et conformité mondiale

• The ingredient entry serves as a development reference; it does not certify the supplied material or completed cosmetic; No authorization for the final cosmetic is implied.

5. Sécurité et évaluation des risques

The percentage is shown for cosmetic development; it should not be read as a drug authorization or OTC listing so patch response and stability should be checked on the finished product.

6. Stabilité et conditionnement

Protect sealed bulk from warmth and direct light; take oxidation sensitivity into account when selecting the final pack; confirm compatibility and stability using the selected formula and pack.

7. Formulations d'allégations (à faire / à éviter)

• The listed cosmetic direction for Centella Asiatica Extract emphasizes Centella botanical.

• The development record does not demonstrate drug effects, cures, or certification claims that go beyond the documented ingredient information.
• The ingredient note for Centella Asiatica Extract offers no support for skin whitening, acne treatment, antiperspirant use, sun protection, or hair growth.

1. INCI et CAS

INCI: Asiaticoside · CAS: 16830-15-2

2. Rôle dans la formule

Asiaticoside is listed as a Centella-associated glycoside in this development reference. The recorded formula also lists Centella Asiatica Extract and Madecassoside. Review this ingredient within the recorded combination; finished-formula comfort claims require supporting evidence.

3. Niveaux d'emploi typiques (repère de formulation)

• For the reference allocation, the recorded amount is 0.2% w/w.

Same cool-down handling as other Centella glycosides.

4. Sources réglementaires et conformité mondiale

• This note is supplied for formulation development; it does not verify or approve the material grade or completed formula; The finished cosmetic is outside the approval represented by this note.

5. Sécurité et évaluation des risques

Treat the listed amount as cosmetic-development guidance; it should not be read as a drug authorization or OTC listing so the finished cosmetic should receive patch and stability checks.

6. Stabilité et conditionnement

Keep the ingredient in cool, closed bulk storage away from sunlight; choose a package with oxidation sensitivity in view; confirm compatibility and stability using the selected formula and pack.

7. Formulations d'allégations (à faire / à éviter)

• Supports the second Centella marker

• This cosmetic guide cannot verify claims of drug action or cure, or a product certification outside the supporting records.
• The ingredient note for Asiaticoside should not be cited in support of skin whitening, acne care, sweat reduction, sun protection, or hair-growth outcomes.